A five-day modified fast, repeated monthly, reduced Crohn's disease symptoms in 69% of patients in a 2026 randomized controlled trial. The fasting mimicking diet (FMD) reversed autoimmune pathology in animal models of multiple sclerosis and inflammatory bowel disease years earlier. Now human data is catching up.
The FMD stands apart from other dietary interventions because it targets a specific mechanism: killing off damaged and autoreactive immune cells during the fasting phase, then regenerating a fresh immune system from stem cells during refeeding. No supplement or elimination diet does this.
What Is the Fasting Mimicking Diet?
The fasting mimicking diet was developed by Valter Longo at the USC Longevity Institute. It is a 5-day modified fast designed to trigger the metabolic and cellular effects of water fasting while still providing enough calories to be safe and tolerable.
The protocol follows a specific caloric and macronutrient structure:
- Day 1: ~1,100 calories (roughly 10% protein, 56% fat, 34% carbs)
- Days 2 through 5: ~725 calories per day (~9% protein, ~44% fat, ~47% carbs)
- All food is plant-based: olives, nuts, soups, herbal teas, kale crackers, energy bars
One cycle lasts five days. The standard protocol calls for one cycle per month for three or more consecutive months, with normal eating between cycles.
ProLon is the commercial kit ($249 per cycle) that packages these meals into pre-portioned boxes. It was used in most published trials. A DIY version following the same macronutrient ratios produces similar metabolic effects, though compliance is harder to verify.
How FMD Triggers Immune Regeneration
The autoimmune benefit of FMD operates in two phases. Both matter. The regeneration happens during refeeding, not during the fast itself.
Phase 1: Destruction (Days 1 through 5)
Sustained caloric restriction over five days activates several cascading processes. Circulating white blood cells drop by 40 to 50%. The body preferentially destroys old, damaged, and autoreactive immune cells through autophagy. IGF-1 and mTOR signaling decline sharply, removing the growth signals that sustain inflammatory T cells. Pro-inflammatory TH17 cells decrease. TH1 cells decrease.
This is selective destruction. The immune system cannibalizes its weakest and most dysfunctional components first.
Phase 2: Regeneration (Days 6 through 10)
When normal eating resumes, hematopoietic stem cells activate and begin producing new immune cells. These naive cells have not been primed against self-antigens. Regulatory T cells (Tregs) increase, restoring immune tolerance. The net effect is a partial immune reset: fewer autoreactive cells, more regulatory cells, and a shifted balance away from the inflammatory dominance that drives autoimmune disease.
This two-phase cycle is why monthly repetition matters. Each cycle clears more autoreactive cells and builds a progressively healthier immune repertoire.
The Evidence by Autoimmune Condition
Crohn's Disease: Grade B (Human RCT, 2026)
The strongest evidence for FMD in autoimmune disease comes from a randomized controlled trial published in Nature Medicine in January 2026. Researchers at Stanford and USC enrolled 97 adults with mild-to-moderate Crohn's disease and assigned them to either three monthly FMD cycles or their usual diet.
Results after three months: 69.2% of FMD patients achieved clinical response, compared to 43.8% in the control group. Clinical remission reached 64.6% in the FMD group versus 37.5% in controls. Fecal calprotectin, a direct marker of intestinal inflammation, declined significantly in the FMD group while rising in controls.
These are large effect sizes for a dietary intervention. For context, the autoimmune protocol (AIP) diet achieved 73% clinical remission in IBD in the Konijeti 2017 trial, though that study was smaller and uncontrolled. The FMD trial is methodologically stronger: randomized, controlled, with objective biomarker endpoints.
The trial excluded patients on biologics or immunomodulators, so these results apply to mild-to-moderate disease managed without heavy immunosuppression.
Multiple Sclerosis: Grade B (Animal + Pilot Human)
Choi et al. published the landmark FMD-autoimmune study in Cell Reports in 2016. In mice with experimental autoimmune encephalomyelitis (EAE), the standard model for multiple sclerosis, periodic 3-day FMD cycles reduced disease severity in all animals and completely reversed symptoms in 20%.
The mechanism was specific and measurable. FMD suppressed TH17 and TH1 cells (the drivers of myelin destruction), increased regulatory T cells, and promoted oligodendrocyte precursor cell regeneration. The mice grew new myelin. Remyelination is the goal that most MS drugs cannot achieve.
A small human pilot confirmed that FMD was safe and well-tolerated in relapsing-remitting MS patients, with quality-of-life improvements. A full-scale human RCT has not yet been completed for MS.
IBD General: Grade B (Animal + Human Markers)
Rangan et al. (Cell Reports, 2019) tested FMD in a chronic DSS colitis model, a standard preclinical model for inflammatory bowel disease. FMD cycles reversed intestinal pathology, reduced inflammation, increased intestinal stem cells, and stimulated protective gut microbiota.
One finding stands out: fecal microbiota transplants from FMD-treated mice into untreated colitis mice reversed the disease. This proved that FMD reshapes the gut microbiome in ways that are independently therapeutic. Water-only fasting, by contrast, improved some inflammatory markers but did not reverse the intestinal pathology. The food composition during FMD matters, not just the caloric restriction.
A parallel human arm showed that three FMD cycles reduced markers of systemic inflammation in healthy volunteers. The 2026 Crohn's RCT confirmed these preclinical findings in actual IBD patients.
Type 1 Diabetes: Grade C (Animal Only)
In mouse models of type 1 diabetes, FMD cycles reprogrammed pancreatic cells and partially reversed insulin deficiency. The proposed mechanism: autophagy clears damaged beta cells, then stem cell activation during refeeding generates new insulin-producing cells. No human trial has tested this. The evidence remains preclinical and speculative for T1D.
Rheumatoid Arthritis: Grade C (Indirect)
No study has directly tested FMD in rheumatoid arthritis. The mechanistic rationale is strong: RA is driven by TH17-mediated joint inflammation, and FMD suppresses TH17 cells across multiple models. Prolonged fasting (not FMD specifically) has shown temporary RA symptom improvement in older studies. FMD may offer a more sustainable version of this effect. Until direct evidence exists, this remains Grade C.
The FMD Protocol Step by Step
Discuss this protocol with your doctor before starting. FMD is not appropriate for everyone.
Before You Start
Get baseline bloodwork: CBC with differential, CRP, fecal calprotectin (if IBD), fasting glucose, and any condition-specific markers. These establish your reference point for measuring response. Weigh yourself. Ensure your BMI is above 18.5.
Day 1 (~1,100 Calories)
The first day is a transition. Eat approximately 1,100 calories from plant-based sources: nuts, olives, vegetable soups, small portions of complex carbs. Keep protein to roughly 10% of calories. Avoid animal products. Drink water and herbal tea freely.
Days 2 Through 5 (~725 Calories Per Day)
This is the core restriction phase. Approximately 725 calories per day, predominantly from plant fats and complex carbs. Protein drops to 9% of calories. Typical foods: vegetable soup, olives, kale chips, small portions of nuts, herbal tea. Energy will be low. Light activity only. No intense exercise.
Days 6 Through 10 (Refeeding)
This phase is where immune regeneration occurs. Resume normal eating gradually. Day 6: light meals, soups, cooked vegetables, small portions. Days 7 through 10: return to your full diet. If you follow an anti-inflammatory or AIP diet, return to that. The refeeding phase activates hematopoietic stem cells. Do not rush it.
Repeat Monthly
Complete one FMD cycle per month for at least three consecutive months. The Crohn's RCT used three cycles. Longo's general longevity research suggests three to six cycles for maximum benefit. After completing the initial series, some practitioners recommend quarterly maintenance cycles.
Who Should Not Do FMD
FMD is contraindicated or requires physician supervision in several populations:
- BMI below 18.5: Caloric restriction is dangerous when underweight
- Pregnancy or breastfeeding: Insufficient caloric intake risks fetal/infant development
- Active eating disorder or history of disordered eating: FMD can trigger restrictive patterns
- Type 1 diabetes on insulin: Blood sugar management during severe caloric restriction requires medical oversight
- Immunosuppressant medications: The Crohn's RCT excluded these patients; interactions are unknown
- Under 18 or over 70: Safety data in these age groups is limited
- Severe malnutrition or cachexia: Any caloric restriction is contraindicated
If you take low-dose naltrexone (LDN) or other immune-modulating compounds, discuss timing with your prescriber. The immune cell turnover during FMD could alter the pharmacodynamics of these agents.
FMD vs Other Fasting Approaches
FMD vs Water Fasting
Water fasting triggers similar metabolic shifts but is harder to sustain and carries higher risk. Critically, the Rangan 2019 study showed that water-only fasting improved some inflammatory markers but did not reverse intestinal pathology. FMD did. The plant-based food composition during FMD appears to provide substrate for beneficial microbiome shifts that pure water fasting misses.
FMD vs Intermittent Fasting (16:8)
Daily time-restricted eating reduces caloric intake and may improve metabolic markers. It does not produce the deep immune cell turnover that five consecutive days of severe restriction triggers. The 40 to 50% white blood cell reduction seen in FMD requires sustained multi-day caloric deprivation. A 16-hour overnight fast cannot reach this threshold. For a full comparison of time-restricted eating protocols in autoimmune disease, see our intermittent fasting for autoimmune disease guide.
FMD vs AIP Diet
The autoimmune protocol diet removes immune-triggering foods. FMD regenerates the immune system itself. These are complementary strategies targeting different mechanisms. Following AIP as your baseline diet and adding periodic FMD cycles is a reasonable combination. The AIP handles ongoing antigen exposure; the FMD addresses the autoreactive immune cell population directly.
For a broader view of supplement and dietary strategies across conditions, see the best supplements for autoimmune disease guide.
Frequently Asked Questions
How long does the fasting mimicking diet take to help autoimmune symptoms?
The Crohn's disease RCT showed clinical response after three monthly 5-day cycles, roughly 12 weeks total. Some participants reported improvements after the first cycle. The immune regeneration mechanism requires multiple cycles to produce measurable shifts in inflammatory markers and immune cell populations.
Can you do FMD while on immunosuppressants?
The Crohn's RCT excluded patients on biologics or immunomodulators. If you take immunosuppressants, discuss FMD with your prescribing physician before attempting it. The caloric restriction and immune cell turnover during FMD could interact with immunosuppressive therapy in unpredictable ways.
Is ProLon necessary or can you do FMD yourself?
ProLon ($249 per cycle) is the commercial kit used in most clinical trials. A DIY version following the same macronutrient ratios (Day 1: ~1,100 calories; Days 2 through 5: ~725 calories; ~9% protein, ~44% fat, ~47% carbs from plant sources) should produce similar metabolic effects. The key constraint is keeping protein low enough to suppress IGF-1 and mTOR signaling.
Is fasting mimicking diet safe for Hashimoto's?
No RCT has tested FMD specifically in Hashimoto's thyroiditis. The general autoimmune mechanism (TH17 suppression, Treg expansion, immune cell regeneration) is relevant to Hashimoto's pathology. Caloric restriction can temporarily affect thyroid hormone conversion. Monitor thyroid labs before and after FMD cycles and work with your endocrinologist.
What is the difference between fasting mimicking diet and intermittent fasting for autoimmune disease?
Intermittent fasting (16:8 or similar) does not trigger the deep immune regeneration seen with FMD. The 5-day sustained caloric restriction produces a 40 to 50% reduction in white blood cells, activates autophagy, and suppresses mTOR signaling at levels that daily time-restricted eating cannot reach. The refeeding phase after FMD then triggers stem cell-driven immune renewal.
The Bottom Line
The fasting mimicking diet has the strongest emerging evidence of any dietary intervention for immune regeneration in autoimmune disease. The 2026 Crohn's RCT provides Grade B human evidence. The MS and IBD preclinical data provide compelling mechanistic support. For other autoimmune conditions, the rationale is sound but direct evidence is still needed.
FMD is not a replacement for medical treatment. It is a periodic dietary protocol that may complement existing therapy by addressing the root immune dysregulation rather than just suppressing symptoms. Three monthly cycles is the minimum tested protocol.
Take the free 3-minute quiz to find your personalized autoimmune protocol, including whether FMD fits your specific condition, severity, and treatment goals.
This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any new dietary protocol, especially if you take medications or have a chronic condition. The fasting mimicking diet involves significant caloric restriction and is not appropriate for everyone.
Sources:
- Fasting-mimicking diet in patients with mild-to-moderate Crohn's disease: a randomized controlled trial. Nature Medicine, 2026. DOI: 10.1038/s41591-025-04173-w
- Choi IY et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Reports, 2016;15(10):2136-2146. PMID: 27239035
- Rangan P et al. Fasting-mimicking diet modulates microbiota and promotes intestinal regeneration to reduce inflammatory bowel disease pathology. Cell Reports, 2019;26(10):2704-2719.e6. PMID: 30840892
- Wei M et al. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Nature Communications, 2024.
- Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metabolism, 2014;19(2):181-192. PMID: 24440038